'A first for cancer research': New approach to study tumors
Current drugs to treat malignant tumors may be successful at reaching the tumor site but often fail to fully reach the cancerous cells in tumors.
Aug 21, 2019
0
5
Current drugs to treat malignant tumors may be successful at reaching the tumor site but often fail to fully reach the cancerous cells in tumors.
Aug 21, 2019
0
5
Unlike many other cancers, most pancreatic tumors are rock hard.
Aug 8, 2019
0
62
Kobe University and Alfresa Pharma Corporation have developed a novel medical device with a non-woven fabric style made of bioabsorbable material.
Aug 5, 2019
0
0
The Ivy Brain Tumor Center at the Barrow Neurological Institute, has released the results of its recent Phase 0 clinical trial of the breast cancer drug ribociclib (Kisqali) for the treatment of recurrent glioblastoma. The ...
Jul 25, 2019
0
8
An artificial nose developed at Tampere University, Finland, helps neurosurgeons to identify cancerous tissue during surgery and enables more precise excision of tumors.
Jun 17, 2019
0
4
A study published today in PLOS ONE discovered the origin of severely disfiguring masses of cells, called neurofibromas, that gradually develop throughout the skin of patients afflicted with Neurofibromatosis 1 (NF1). The ...
May 21, 2019
0
2
Although classical Hodgkin's lymphoma is generally easily treatable today, many aspects of the disease still remain a mystery. A team at the Max Delbrück Center led by Professor Claus Scheidereit has now identified an important ...
May 14, 2019
0
6
Small spots on CT scans of the lungs of children with muscle cancer do not have an adverse effect on survival, according to an international research team in the Journal for Clinical Oncology. This conclusion has direct consequences ...
Feb 15, 2019
0
9
For cancer to spread, it needs a hospitable environment in distant organs. This fertile "soil" can provide a home to circulating malignant cells. Recent research has shown that cancer cells from the primary tumor can help ...
Jan 15, 2019
0
6
Researchers have identified a new potential immunotherapy target in pancreatic cancer, which so far has been notoriously resistant to treatment with immune checkpoint blockade drugs effective against a variety of other cancers.
Jan 11, 2019
0
17